Aortech International PLC Fundamentals Datasheet and Stock Analysis

Profile

Aortech International PLC Company Logo
AorTech International plc is a biomaterials and medical device intellectual property (IP) company. The Company is focused on the commercialization of its biomedical polymer technology, components and medical devices. The Company has developed biostable, implantable polymers, including Elast-Eon and ECSil, which are long-term implantable co-polymers. Its Elast-Eon technology is available in a range of mechanical properties (Elastomers to rigid polymers), 70 Shore A to 80 Shore D. Its ECSil technology is available in a range of mechanical properties, but extends the softer materials to 70 Shore A. The Company has developed Elast-Eon and Reaction Injection Molding (RIM) technology for use in high-precision medical device components. Its polymers are developed and used in cardiology and urological applications, including pacing leads, cardiac cannulae, stents and neuro stimulation devices. These polymers can be processed using conventional thermoplastic extrusion and molding techniques.

  • Current Price:
     64.50p
  • Industry:
     Health Care
  • Sector:
     Health Care
  • ISIN:
     GB0033360586
  • Market Sector:
     AIM
  • Main Indices:
     FTSE AIM
  • Country of register:
     Great Britain
  • Currency:
     N/A
  • Shares in Issue:
     15m
  • Market Cap:
     £3m
  • Date Listed:
     01/09/2003
Operation Breakdown
Geographical - by origin (turnover)
Product (turnover)

Loading...

Activity Data Not Available

Company Information

Chairman: William D Brown  Non-Executive Director: John McKenna James Gordon Wright  

  • Registrars:
     Equiniti
  • Address:
     C/o Kergan & Stewart LLP, 163 Bath Street, Glasgow
  • Phone:
     
  • Website:
     http://www.aortech.com/
Analysis
Composite Ranking: 39
Historic EPS Ranking: 7
Forecast EPS Ranking: 
Price Relative Strength: 79
Industry Strength: E
SMR Ranking: 
ROCE Ranking: F
Accumulation/Dist: C
Mkt Accumulation/Dist: C
Unbroken Annual EPS: E
Unbroken Interim EPS: E
PEG Current Ranking: A
PEG Forecast Ranking: A
PE Current Ranking: A
PE Forecast Ranking: A
Margin Current Ranking: E
Margin Forecast Ranking: D
Chart
Add Indicator




loading




Takes the average of data over a period of time, and migrates the period across the data series one data point at a time. This formula smooths a data series and makes analysing volatile data easier.
Fundamentals
201120122013201420152016201720182019E
Day/Month31/331/331/331/331/331/331/331/331/3
Revenue$m2.445.040.310.420.840.750.610.54$m0.48
Operating Profit/(loss)$m(4.02)0.04(1.21)(0.76)(0.46)(0.57)(0.24)(0.04)$m0.00
Profit Before Tax$m(3.89)0.06(3.26)(0.82)(0.33)(0.60)(0.24)(0.04)$m(0.55)
Profit After Tax$m(3.89)0.06(3.26)(0.82)(0.37)(0.60)(0.24)(0.04)$m0.00
Profit After Tax (from discontinued operations)$m0.000.002.41(0.49)0.000.000.000.00$m0.00
Overall Profit for the Period$m0.000.06(0.85)(1.31)(0.37)(0.60)(0.24)(0.04)$m0.00
EPS Growth%0.000.000.000.000.000.000.000.00%(100.00)
Earnings Per Share¢(80.42)1.18(32.00)(8.07)(7.27)(11.39)(4.05)(0.75)p0.00
Op. Cash Flow P/S¢(49.00)(1.79)0.11(0.01)(0.06)0.02(0.04)0.09$0.00
Cash Flow P/S Grth%0.000.000.000.000.000.000.000.00%0.00
Net Cash Flow P/S¢0.000.000.000.000.000.000.000.00$0.00
Capital Exp P/S$0.000.000.000.000.000.000.000.00$0.00
Tax Rate%0.000.000.000.000.000.000.000.00%0.00
P/E Ratiox0.0024.700.000.000.000.000.000.00x0.00
P/E Growth$0.000.000.000.000.000.000.000.00$0.00
Turnover Per Share$50.49104.250.000.000.000.000.000.00$0.00
Pre-Tax Profit / Share$(80.43)1.180.000.000.000.000.000.00$0.00
Operating Margin%(87.34)0.00(384.98)(182.78)(54.76)(76.00)(39.34)(7.41)%0.00
ROCE%0.00(42.76)(76.63)(25.95)(18.56)(41.22)(17.98)(3.10)%0.00
ROE%(40.88)(49.50)(18.42)(38.15)(14.37)(29.06)(15.41)(3.21)%0.00
Mkt Cap$m9.3818.018.5012.133.453.691.955.92$m0.00
Dividend Per Share¢0.000.000.000.000.000.000.000.00p0.00
DPS Growth%0.000.000.000.000.000.000.000.00%0.00
Dividend Yield%0.000.000.000.000.000.000.000.00%0.00
Dividend Coverx0.000.000.000.000.000.000.000.00x0.00
Shareholder Funds$m5.015.094.112.752.401.761.321.42$m0.00
Net Borrowings$m(2.21)(1.92)(0.99)(0.64)(0.36)(0.31)(0.11)(0.59)$m0.00
Net Assets$m5.015.094.112.752.401.761.321.42$m0.00
Net Assets P/S$58.290.000.000.000.000.000.000.00$0.00
Financials
Latest Forecast
Div Yield0.0%0.0%
Div Cover0.0%0.0%
Op Margin-7.4%0.0%
ROCE0.0%
Director Deals
Traded Action Notifier Price Amount Value
09-Oct-13BuyEdward McDaid85.00p25,000£21,250
08-Oct-13BuyRoy Walter Mitchell83.88p25,000£20,970
12-Aug-11BuyFrank Maguire192.0025,0000,000
  Rows per page
Shareholders
15m    Major: 152%    Director: 2%
Notifier Holding Value
James Gordon Wright308,311Æ,860.60
  Rows per page
Gearing & Cover
News
News Title Date Time Source
Holding(s) in Company05-Sep-1807:00RNS
Holding(s) in Company30-Aug-1811:18RNS
Result of AGM23-Aug-1814:03RNS
AGM Statement23-Aug-1807:00RNS
Holding(s) in Company26-Jul-1815:33RNS
Second Price Monitoring Extn25-Jul-1816:40RNS
Price Monitoring Extension25-Jul-1816:35RNS
Final Results20-Jul-1807:00RNS
New Patent Issued04-Jul-1807:00RNS
Development and Supply Agreement with RUA Medical28-Jun-1807:00RNS
First PagePrev PageNext Page  Rows per page
Broker Opinion
Date Broker Name Rec Price Old Price Target New Price Target Broker Change

No data

  Rows per page
Notes

This functionality requires you to login

Click here to login
Or register for a new account